ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.9843
+0.0078 (0.80%)
Apr 28, 2025, 4:00 PM EDT - Market closed

ABVC BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
15792096105
Upgrade
Market Cap Growth
-19.29%-19.29%-55.74%-78.95%-8.30%24.82%
Upgrade
Enterprise Value
189122295109
Upgrade
Last Close Price
1.000.591.166.2533.9051.00
Upgrade
PS Ratio
22.9114.1858.7220.85269.96216.85
Upgrade
PB Ratio
10.719.987.146.2510.8339.35
Upgrade
P/TBV Ratio
12.275.895.766.5310.8630.46
Upgrade
EV/Sales Ratio
35.1818.4180.2422.60266.23225.32
Upgrade
Debt / Equity Ratio
4.414.412.211.060.382.54
Upgrade
Asset Turnover
0.070.070.020.080.030.05
Upgrade
Inventory Turnover
----0.39-
Upgrade
Quick Ratio
0.050.050.030.181.720.97
Upgrade
Current Ratio
0.330.330.270.542.071.27
Upgrade
Return on Equity (ROE)
-531.91%-531.91%-368.89%-269.48%-208.73%-835.04%
Upgrade
Return on Assets (ROA)
-38.38%-38.38%-48.71%-81.16%-57.83%-57.36%
Upgrade
Return on Capital (ROIC)
-74.08%-74.08%-79.26%-100.17%-67.64%-74.68%
Upgrade
Earnings Yield
-32.58%-67.87%-87.01%-81.21%-13.37%-9.35%
Upgrade
FCF Yield
-12.02%-25.04%-47.01%-37.18%-7.93%-4.36%
Upgrade
Buyback Yield / Dilution
-169.26%-169.26%-36.92%-26.39%-27.07%-12.67%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q